Deferred Tax Assets, Gross of Protagenic Therapeutics, Inc.\new from 30 Jun 2013 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Protagenic Therapeutics, Inc.\new quarterly Deferred Tax Assets, Gross in USD history and change rate from 30 Jun 2013 to 31 Dec 2024.
  • Protagenic Therapeutics, Inc.\new Deferred Tax Assets, Gross for the quarter ending 31 Dec 2024 was $8,713,000, a 23% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Change (%)

Protagenic Therapeutics, Inc.\new Quarterly Deferred Tax Assets, Gross (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $8,713,000 +$1,642,000 +23% 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q4 2023 $7,071,000 +$1,513,000 +27% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q4 2022 $5,558,000 +$137,000 +2.5% 31 Dec 2022 10-K/A 14 May 2024 2023 FY
Q4 2021 $5,421,000 +$1,300,000 +32% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q4 2020 $4,121,000 +$418,000 +11% 31 Dec 2020 10-K 07 Apr 2022 2021 FY
Q4 2019 $3,703,000 +$661,000 +22% 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q4 2018 $3,042,000 +$279,000 +10% 31 Dec 2018 10-K 29 Apr 2020 2019 FY
Q4 2017 $2,763,000 +$243,000 +9.6% 31 Dec 2017 10-K 29 Mar 2019 2018 FY
Q4 2016 $2,520,000 +$1,148,000 +84% 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q4 2015 $1,372,000 +$445,000 +48% 31 Dec 2015 10-K/A 08 May 2017 2016 FY
Q2 2015 $21,994,000 +$171,000 +0.78% 30 Jun 2015 10-K 25 Sep 2015 2015 FY
Q4 2014 $927,000 31 Dec 2014 8-K/A 12 Jul 2016 2015 FY
Q2 2014 $21,823,000 -$604,000 -2.7% 30 Jun 2014 10-K 25 Sep 2015 2015 FY
Q2 2013 $22,427,000 30 Jun 2013 10-K 14 Oct 2014 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.